Skip to main content
. 2015 Mar 16;10(3):e0121976. doi: 10.1371/journal.pone.0121976

Table 4. Classification of connective tissue diseases with cardiovascular involvement, n (%).

Manifestation DM/PM SSC RA PSS SLE MCTD UCTD p value
Cardiovascular involvement 53 (61.6) 48 (68.6) 70 (71.4) 59 (62.1) 30 (54.5) 9 (56.2) 13 (81.2) 0.243
Arrhythmia 19 (22.1) 25 (35.7) 23 (23.5) 18 (18.9) 11 (20.0) 3 (18.8) 5 (31.2) 0.238
Myocardial function limitation 32 (37.2) 33 (47.1) 48 (49.0) 38 (40.0) 20 (36.4) 5 (31.2) 8 (50.0) 0.473
Pericardial disease 8(9.4) 9 (12.9) 12 (12.2) 2(2.1) 15 (27.3) 3 (18.8) 0(0.0) 0.004
Pulmonary arterial hypertension 11 (12.8) 17 (24.3) 14 (14.3) 10 (10.5) 10 (18.2) 2 (12.5) 1 (6.2) 0.059
Valvular disease 18 (20.9) 22 (31.4) 27 (27.6) 25 (26.3) 11 (20.0) 3 (18.8) 4 (25.0) 0.709
Coronary artery calcium 10 (11.6) 4 (5.7) 12 (12.2) 2 (2.1) 5 (9.1) 1 (6.2) 1 (6.2) 0.167
Myocardial ischemia 15 (17.4) 12 (17.1) 25 (25.5) 15 (15.8) 5(9.1) 2 (12.5) 3 (18.8) 0.279

DM/PM: polymyositis and dermatomyositis; MCTD: mixed connective tissue disease; PSS: primary Sjogren’s syndrome; RA: rheumatoid arthritis; SLE: systemic lupus erythematous; SSC: systemic sclerosis; UCTD: undifferentiated connective tissue disease.